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ed 19.2% (24/125) more positive cases, 50% (12/24) were
PV18, 37.5% (9/24) HPV16 and in 12.5% (3/24) ampliﬁcation
f more than one genotype occurred.
Conclusion: In conclusion, target region for ampliﬁcation
f HPV DNA is a determinant factor in the molecular diagno-
is of cervical infection. Moreover, quantiﬁcation of the viral
oad by qRT-PCR SYBR Green-L1 assay allows to determines
PV infection, viral load, genotyping especially in women
ith high risks lesions by PAP smear.
oi:10.1016/j.ijid.2010.02.674
4.044
abies cases in dog markets in Kaduna state, northern
igeria
. Ehimiyein1,∗, M. Niezgoda1, L. Orciari 1, I. Kuzmin1,
. Osinubi1, I.O. Ehimiyein2, D. Adawa2, S. Abdullahi 2, A.
gunkoya2, C.E. Rupprecht1
Centers for Disease Control and Prevention, Atlanta, GA,
SA
Ahmadu Bello University, Zaria, KD, Nigeria
Background: The study was conducted to determine the
otential role of dog markets in the epidemiology of rabies
n Kaduna.
Methods: Thirty dog brain samples were collected from
ifferent dogs brought to the dog markets in Kaduna State,
igeria. the dog brain tissues were tested using several
ssays: Direct Rapid Immunohistochemistry Test (dRIT);
irect Fluorescent Antibody Test (DFA); the Mouse Inocu-
ation Test (MIT); and a Reverse Transcriptase- Polymerase
hain Reaction Test (RT-PCR). Both apparently healthy and
linically ill dogs were brought to the markets.
Results: Fifteen (50%) samples tested positive for rabies
irus antigens. All the samples tested positive by the dRIT
nd DFA tests, with +4 staining intensity and antigen distri-
ution.
The inoculated mice developed signs of rabies by day
post inoculation via the MIT. All positive samples were
equenced after RT-PCR detection. Detected rabies viruses
ere similar to other variants reported previously from Nige-
ia.
Conclusion: In this preliminary study, the presence of
abies was conﬁrmed in the local dog markets, and may
lay an important role in the spread of rabies. Both the
utchers and the buyers are at risk during the processing
nd sale of the dog meat. Additional work should be done
t other animal markets throughout Nigeria. Greater aware-
ess is needed on the danger rabies may pose on both human
nd animal populations from such activities.
oi:10.1016/j.ijid.2010.02.675
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linical and epidemiological aspects of mumps virus infec-
ion
. Maninska ∗, M. Arapova
General hospital -Strumica, Strumica, Macedonia
Background: Mumps is an acute viral infection character-
zed by a non-speciﬁc prodrome, followed by acute onset of
nilateral or bilateral tender swelling of parotid or other
alivary glands. The aim of the study is to describe an
pidemic form of mumps viral infection in the region of
trumica.
Methods: Retrospective clinical studi of 1248 mumps
ases diagnosed in the last 2 years in the Department of
nfectious Diseases in Strumica.
Results: Between 1 March 2008 and 31 March 2009, a total
f 1248 mumps cases were notiﬁed in our department. In
otal, 533 cases were hospitalized for clinical indications.
he majority of patient had epididymo-orchitis 253 (47%).
nilateral involvement was found in 20-30% of patients,
hereas bilateral involvement occurs in fewer than 2% of
ases. Other localizations of the mumps infection were uni-
ateral parotitis 225 patients (42,2%), meningitis 43 (8,1%),
nd pancreatitis 12 (2,25%). The peak incidence of mumps
n 2008 was in June 290 patients, July 225 and May 187
atients.
Of the 1248 reported cases of mumps, 49,6% were
etween 15-19 years old, and 416 (79%) were male. Vac-
ination data were available and 96% of them had been
accinated. Mumps vaccination coverage has been high since
ts introduction in 1983, except for a period in the 1992
nd 1993. Individuals born in 1992-1993 had coverage only
ith one dose of mumps vaccine. Patients who had doc-
mentation of receiving only one dose of vaccine were
t greater risk than those who received tho doses. Treat-
ent was supportive, symptom-based. No deaths have been
eported.
Conclusion: The main strategies for controlling a mumps
utbreak are to deﬁne the risk population and transmission
etting, identify and isolate suspected cases, and to rapidly
dentify and vaccinate susceptible persons. Vaccination is
he cornerstone of mumps prevention.
oi:10.1016/j.ijid.2010.02.676
4.046
patial and temporal trends of the Lassa fever epidemic
n Nigeria 2001 — 2009, with particular reference to the
do State experience
. Akpede1,∗, D. Asogun1, P. Okokhere1, S. Okogbenin1, H.
kpan2, J. Ehiemuan1, C. Happi3, S. Gunther4
Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria
Federal Ministry of Health, Abuja, Nigeria
UCH Ibadan, Ibadan, Nigeria
Bernhard-Nocht-Institute for Tropical Medicine, Hamburg,
ermany
Background: The initial interest following the report of
he Lassa fever (LF) epidemic in Nigeria in 1969 waned con-
iderably unlike in the Mano River Basin countries of Sierra
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Leone, Liberia and Guinea. The NLFSFN was formed in 2007
to meet the need for a structured and sustained response
to the control of the epidemic in Nigeria. We describe the
spread of the epidemic from 2001-2007, the change in its
seasonality, the rise in prevalence and the decline in case
fatality rate (CFR) among hospital patients.
Methods: Review of surveillance data at the Federal Min-
istry of Health and the Institute of Lassa Fever Research and
Control, ISTH, Irrua and review of the case load and out-
come of suspected LF at the ISTH. The diagnosis of LF was
based on deﬁned criteria.
Results: From 2001 — 2006, 1-3 (average 1.7 or 5%) of
the 36 States and the Federal Capital Territory reported LF
compared to 7-12 (average 9.7) States in 2007-2009 (OR (95%
CI) = 0.26 (0.13, 0.53), p < 0.01). Suspected LF constituted
0.53% of 41,440 admissions in 2001-06 compared to 2.16%
of 35,484 admissions in 2007-09 (RR (95% CI) = 1.7 (1.64,
1.76), p « 0.001). Ninety (76%) of 118 cases of suspected
LF managed at the ISTH in 2001-04 were seen in January
to March compared to 49/103 (48%) in 2004-05 (RR (95%
CI) = 1.9 (1.32,
2.62), p « 0.001) and 271/765 (35%) in 2007-09 (RR (95%
CI) = 1.56 (1.09, 2.24), p = 0.02 for 2007-09 versus 2005-06).
CFR from suspected LF was 97/221 (43.9%) in 2001-06 versus
102/768 (13.3%) in 2007-09 (RR (95% CI) = 0.61 (0.53, 0.7), p
«0.001). Overall, the diagnosis of LF was conﬁrmed in 16-25%
of cases of suspected LF in 2008-09. In each of the 3 Sena-
torial Districts in Edo State, the prevalence of suspected LF
as seen at the ISTH increased by >149% from 2008 — 2009
while that of conﬁrmed LF increased by >73%.
Conclusion: Both awareness of the epidemic and the
index of suspicion in clinical diagnosis have increased as
immediate gains from the LF control activities of the
NLFSFN. The seasonality of LF has changed while the preva-
lence in Nigeria may have increased, perhaps in part due
to the increased awareness and index of suspicion. Assis-
tance of the international community is required to scale
up the control initiatives, particularly with regard to capac-
ity building in surveillance, laboratory diagnosis and case
management.
doi:10.1016/j.ijid.2010.02.677
84.047
Immunocompromised patients with shingles - Therapeutic
approach
L. Zabaznoska1,∗, L. Ilieva1, V. Markovski 1, V. Semenakova-
Cvetkovska2
1 University Hospital of Infectious Diseases, Skopje, Mace-
donia
2 Clinic for Infectious Diseases, Skopje, Macedonia
Background: The complexity of the therapeutic approach
of the immunocompromised patients is determinate by
the capacity of their immunoresponse corresponding with
the arising infection. Among the patients with shingles
with a comorbide immunodeﬁciency syndrome such as pri-
mary hypogamaglobulinaemia or secondary lymphopenia as
a result of a long lasting immunosuppressive therapeutic
treatment that is even more complex, due to threatening
viral generalization, including visceral generalization of the
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llness as well as dermal and pulmonary bacterial superin-
ection.
Methods: During the 6 year long period, 20 immuno-
ompromised patients with shingles were hospitalized and
ealed in our department. Dermal eruptions were spreaded
n several dermatoms, in 8 patients with dermal general-
zation. Visceral generalization appeared in 4 cases with all
onsecutive disorders. Diagnostic criteria, including com-
lete blood count (CBC), sedimentation, chemistry proﬁle
f renal and liver function tests, bacteriological (inducted
xpectorated) sputum sample testing, blood culture, pleural
uid analysis, chest xray and tomography, were determin-
ng moments in the diagnostic procedure and therapeutic
reatment.
Results: Appearance of the Acyclovir (for oral or i.v.
pplication), as a systemic virostatic with high efﬁciency,
ramatically changed the evolution of the illness in this
roup of patients, their clinical symptomatology and expres-
ion, with the drastic reduction of the sequels and the
pilogue of the illness. Due to the effect of viral repli-
ation blocking, its efﬁciency is evident, especially if it
s applicated within the ﬁrst 3 days of the illness (24-
8-72 hours after the appearance of the ﬁrst symptoms)
t the period of the most intense viral replication. These
atients were parenterally/peroral treated with Acyclovir
Virolex) and antibiotics - Penicillines, II and III generation
ephalosporines, Aminoglycosides, Macrolides, Quinolones,
lindamycin, Lincomycin, Co-trimoxazol.
Conclusion: All patients showed satisfying resolve of the
ermal lesions, resolution of the pulmonary inﬂammation
nd correction of the chemistry proﬁle of renal and liver
unction as well as abrogation of all clinical symptoms and
ubjective difﬁculties. Is it necessary to point out the impor-
ance of the substitutional and symptomatic therapy that
ave to be implemented simultaneously with antiviral and
ntibiotic therapy, as the only possible and satisfactory way
f treatment of this group of patients along with necessary
ttention and care.
oi:10.1016/j.ijid.2010.02.678
4.048
eculiar case of herpetic viral encephalitis
.-M. Draghici 1,∗, N. Negrut1, A. csep1, I. zaporojan2, M.
etric1
University of Oradea, Oradea, Romania
Hospital of Pneumophtysiology, Oradea, Romania
Background: Herpetic viral encephalitis is a severe
isease, especially in neonates and immunocompromised
osts. HSE with HSV 2 appears more frequently in persons
ounger than 20 and older than 50. Immunossupresion may
e the cause of herpes simplex viral encephalitis.
Methods: The case presentation is supported by the infor-
ation found in this patient’s ﬁles from three medical
ervices where he was admitted: Clinic of Internal Medicine,
eurosurgery, and ﬁnally Clinic of Infectious Diseases of the
niversity of Oradea.
Results: A 16 years old rural male patient, presented
tarting with September 2009 headaches, night sweating,
ack of appetite, vomiting, abdominal pain, diarrhea and
